Skip to main content
Erschienen in: Metabolic Brain Disease 4/2017

20.03.2017 | Original Article

Post 6-OHDA lesion exposure to stress affects neurotrophic factor expression and aggravates motor impairment

verfasst von: Phumzile Nomfundo Ngema, Musa Vuyisile Mabandla

Erschienen in: Metabolic Brain Disease | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Chronic exposure to stress amplifies locomotor deficits and exacerbates dopamine neuron loss in an animal model for Parkinson’s disease. The release of neurotrophic factors such as glial cell-line derived neurotrophic factor (GDNF) and neurotrophin-3 (NT-3) following neuronal injury attenuates exacerbated degeneration of these neurons. In this study, the neurotoxin 6-hydroxydopamine (6-OHDA) was injected unilaterally into the medial forebrain bundle of male Sprague Dawley rats. A subset of these rats was subjected to post-lesion restraint stress after which the effect of exposure to stress on locomotor activity (forelimb akinesia test), neurotrophic factor (GDNF and NT-3) and corticosterone concentration was assessed. Exposure to post-lesion stress resulted in increased preference to use the unimpaired forelimb (forelimb ipsilateral to the lesioned hemisphere) in the forelimb akinesia test. The expected increase in both GDNF and NT-3 concentration following injury was not present in the stressed animals. However, both the non-stressed and stressed lesioned groups had decreased neurotrophic factor concentration at one and two weeks post lesion. This decrease was exaggerated in the stressed rats. The decrease in neurotrophic factor concentration was accompanied by an increase in corticosterone concentration in the stressed rats. These findings demonstrate that exposure to post-6-OHDA lesion stress exaggerates dopamine neurodegeneration and enhance motor impairment. This suggests that conditions that result in a hyper-activated hypothalamic-pituitary-adrenal axis such as depression which is concomitant to a Parkinson’s disease diagnosis may be responsible for enhanced dopamine depletion by attenuating neurotrophic factor concentration elevation in the nigrostriatal pathway following neuronal injury.
Literatur
Zurück zum Zitat Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK (2013) GDNF, NGF and BDNF as therapeutic options for neurodegenerations. Pharmacology Therapeutics 138:155–175CrossRefPubMed Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK (2013) GDNF, NGF and BDNF as therapeutic options for neurodegenerations. Pharmacology Therapeutics 138:155–175CrossRefPubMed
Zurück zum Zitat Andrew R, Watson DG, Best SA, Midgley JM, Wenlong H, Petty RKH (1993) The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem Res 18(11):1175–1177CrossRefPubMed Andrew R, Watson DG, Best SA, Midgley JM, Wenlong H, Petty RKH (1993) The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem Res 18(11):1175–1177CrossRefPubMed
Zurück zum Zitat Bäck S, Raki M, Tuominen RK, Raasmaja A, Bergström K, Männistö PT (2013) High correlation between in vivo [123I] β-CIT SPECT/CT imaging and post-mortem immunohistochemical findings in the evaluation of lesions induced by 6-OHDA in rats. EJNMMI Res 3:47CrossRef Bäck S, Raki M, Tuominen RK, Raasmaja A, Bergström K, Männistö PT (2013) High correlation between in vivo [123I] β-CIT SPECT/CT imaging and post-mortem immunohistochemical findings in the evaluation of lesions induced by 6-OHDA in rats. EJNMMI Res 3:47CrossRef
Zurück zum Zitat Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guiloteau D, Crossman AR, Bioulac B, Brotchie JM, Gross CE (2001) Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macque model of Parkinson’s disease. J Neurosci 21:6853–6861PubMed Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guiloteau D, Crossman AR, Bioulac B, Brotchie JM, Gross CE (2001) Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macque model of Parkinson’s disease. J Neurosci 21:6853–6861PubMed
Zurück zum Zitat Boix J, Padel T, Paul G (2015) A partial lesion model of Parkinson's disease in mice - characterization of a 6-OHDA-induced medial forebrain bundle lesion. Behav Brain Res 284:196–206CrossRefPubMed Boix J, Padel T, Paul G (2015) A partial lesion model of Parkinson's disease in mice - characterization of a 6-OHDA-induced medial forebrain bundle lesion. Behav Brain Res 284:196–206CrossRefPubMed
Zurück zum Zitat Breese GR, & Traylor TD (1971). Depletion of brain noradrenaline and dopamine by 6‐hydroxydopamine. Br J Pharmacol 42(1):88–99. Breese GR, & Traylor TD (1971). Depletion of brain noradrenaline and dopamine by 6‐hydroxydopamine. Br J Pharmacol 42(1):88–99.
Zurück zum Zitat Chen J, Wang ZZ, Zuo W, Zhang S, Chu SF, Chen NH (2016) Effects of chronic mild stress on behavioural and neurobiological parameters—role of glucocorticoid. Horm Behav 78:150–159CrossRefPubMed Chen J, Wang ZZ, Zuo W, Zhang S, Chu SF, Chen NH (2016) Effects of chronic mild stress on behavioural and neurobiological parameters—role of glucocorticoid. Horm Behav 78:150–159CrossRefPubMed
Zurück zum Zitat Curtius HC, Wolfensberger M, Steinmann B, Redweik U, Siegfried J (1974) Mass fragmentography of dopamine and 6-hydroxydopamine: application to the determination of dopamine in human brain biopsies from the caudate nucleus. J Chromatogr A 99:529–540CrossRef Curtius HC, Wolfensberger M, Steinmann B, Redweik U, Siegfried J (1974) Mass fragmentography of dopamine and 6-hydroxydopamine: application to the determination of dopamine in human brain biopsies from the caudate nucleus. J Chromatogr A 99:529–540CrossRef
Zurück zum Zitat Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson’s disease. Journal of Parkinson’s Disease 3(4):461–491PubMedPubMedCentral Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson’s disease. Journal of Parkinson’s Disease 3(4):461–491PubMedPubMedCentral
Zurück zum Zitat Duty S, Jenner P (2011) Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. Br J Pharmacol 164(4):1357–1391CrossRefPubMedPubMedCentral Duty S, Jenner P (2011) Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. Br J Pharmacol 164(4):1357–1391CrossRefPubMedPubMedCentral
Zurück zum Zitat Hemmerle AM, Herman JP, Seroogy KB (2012) Stress, depression and Parkinson's disease. Exp Neurol 233(1):79–86CrossRefPubMed Hemmerle AM, Herman JP, Seroogy KB (2012) Stress, depression and Parkinson's disease. Exp Neurol 233(1):79–86CrossRefPubMed
Zurück zum Zitat Herrera AJ, Castano A, Venero JL, Cano J, Machado A (2000) The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiol Dis 7:429–447CrossRefPubMed Herrera AJ, Castano A, Venero JL, Cano J, Machado A (2000) The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiol Dis 7:429–447CrossRefPubMed
Zurück zum Zitat Heuer A, Smith GA, Lelos MJ (2012) Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites. Behav Brain Res 228:30–43CrossRefPubMed Heuer A, Smith GA, Lelos MJ (2012) Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites. Behav Brain Res 228:30–43CrossRefPubMed
Zurück zum Zitat Hirsch EC, Jenner P, Przedborski SS (2013) Pathogenesis of Parkinson’s disease. Mov Disord. In press Hirsch EC, Jenner P, Przedborski SS (2013) Pathogenesis of Parkinson’s disease. Mov Disord. In press
Zurück zum Zitat Hwang YP, Kim HG, Han EH, Jeong HG (2008) Metallothionein-III protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a PI3K and ERK/Nrf2-dependent manner. Toxicol Appl Pharmacol 231(3):318–327CrossRefPubMed Hwang YP, Kim HG, Han EH, Jeong HG (2008) Metallothionein-III protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a PI3K and ERK/Nrf2-dependent manner. Toxicol Appl Pharmacol 231(3):318–327CrossRefPubMed
Zurück zum Zitat Jackson-Lewis V, Blesa J, Przedborski S (2012) Animal models of Parkinson's disease. Parkinsonism Related Disorders 18(1):S183–S185CrossRefPubMed Jackson-Lewis V, Blesa J, Przedborski S (2012) Animal models of Parkinson's disease. Parkinsonism Related Disorders 18(1):S183–S185CrossRefPubMed
Zurück zum Zitat Jing X, Shi H, Zhang C, Ren M, Han M, Wei X, Zhang X, Lou H (2015) Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity. Neuroscience 286:131–140CrossRefPubMed Jing X, Shi H, Zhang C, Ren M, Han M, Wei X, Zhang X, Lou H (2015) Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity. Neuroscience 286:131–140CrossRefPubMed
Zurück zum Zitat Kim ST, Choi JH, Chang JW, Kim SW, Hwang O (2005) Immobilization stress causes increases in tetrahydrobiopterin, dopamine and neuromelanin an oxidative damage in the nigrostriatal system. J Neurochem 95(1):89–98CrossRefPubMed Kim ST, Choi JH, Chang JW, Kim SW, Hwang O (2005) Immobilization stress causes increases in tetrahydrobiopterin, dopamine and neuromelanin an oxidative damage in the nigrostriatal system. J Neurochem 95(1):89–98CrossRefPubMed
Zurück zum Zitat Kott JM, Mooney-Leber SM, Shoubah FA, Brummelte S (2016) Effectiveness of different corticosterone administration methods to elevate corticosterone serum levels, induce depressive-like behavior, and affect neurogenesis levels in female rats. Neuroscience 312:201–214CrossRefPubMed Kott JM, Mooney-Leber SM, Shoubah FA, Brummelte S (2016) Effectiveness of different corticosterone administration methods to elevate corticosterone serum levels, induce depressive-like behavior, and affect neurogenesis levels in female rats. Neuroscience 312:201–214CrossRefPubMed
Zurück zum Zitat Liu SQ (2007) Bioregenerative engineering: principles and applications. John Wiley and Sons, HobokenCrossRef Liu SQ (2007) Bioregenerative engineering: principles and applications. John Wiley and Sons, HobokenCrossRef
Zurück zum Zitat Lupien SJ, McEwen BS, Gunnar MR, Heim C (2009) Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 10:434–445CrossRefPubMed Lupien SJ, McEwen BS, Gunnar MR, Heim C (2009) Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 10:434–445CrossRefPubMed
Zurück zum Zitat Lv H, Liu J, Wang L, Zhang H, Yu S, Li Z, Jiang F, Niu Y, Yuan J, Cui X, Wang W (2014) Ameliorating effects of combined curcumin and desferrioxamine on 6-OHDA-induced rat mode of Parkinson’s, disease. Cell Biochem Biophys 70(2):1433–1438CrossRefPubMed Lv H, Liu J, Wang L, Zhang H, Yu S, Li Z, Jiang F, Niu Y, Yuan J, Cui X, Wang W (2014) Ameliorating effects of combined curcumin and desferrioxamine on 6-OHDA-induced rat mode of Parkinson’s, disease. Cell Biochem Biophys 70(2):1433–1438CrossRefPubMed
Zurück zum Zitat Mabandla MV, Russell VA (2010) Voluntary exercise reduces the neurotoxic effects of 6-hydroxydopamine in martenally separated rats. Behavioral brain research 211:16–22CrossRef Mabandla MV, Russell VA (2010) Voluntary exercise reduces the neurotoxic effects of 6-hydroxydopamine in martenally separated rats. Behavioral brain research 211:16–22CrossRef
Zurück zum Zitat Mattson MP, Lovell MA, Furukawa K, Markesbery WR (1995) Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem 65(4):1740–1751CrossRefPubMed Mattson MP, Lovell MA, Furukawa K, Markesbery WR (1995) Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem 65(4):1740–1751CrossRefPubMed
Zurück zum Zitat Patki G, Li L, Allam F, Solanki N, Dao AT, Alkadhi K, Salim S (2014) Moderate treadmill exercise rescues anxiety and depression-like behaviour as well as memory impairment in a rat model of posttraumatic stress disorder. Physiol Behav 130:47–53CrossRefPubMedPubMedCentral Patki G, Li L, Allam F, Solanki N, Dao AT, Alkadhi K, Salim S (2014) Moderate treadmill exercise rescues anxiety and depression-like behaviour as well as memory impairment in a rat model of posttraumatic stress disorder. Physiol Behav 130:47–53CrossRefPubMedPubMedCentral
Zurück zum Zitat Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, San Diego Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, San Diego
Zurück zum Zitat Quik M, O’Neill M, Perez XA (2007) Nicotine neuroprotection against nigrostriatal damage: importance of the animal model. Trends Pharmacology Sci 28:229–235CrossRef Quik M, O’Neill M, Perez XA (2007) Nicotine neuroprotection against nigrostriatal damage: importance of the animal model. Trends Pharmacology Sci 28:229–235CrossRef
Zurück zum Zitat Santiago RM, Barbiero J, Gradowski RW, Bochen S, Lima MM, Da Cunha C, Andreatini R, Vital MA (2014) Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin. Behav Brain Res 259:70–77CrossRefPubMed Santiago RM, Barbiero J, Gradowski RW, Bochen S, Lima MM, Da Cunha C, Andreatini R, Vital MA (2014) Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin. Behav Brain Res 259:70–77CrossRefPubMed
Zurück zum Zitat Schallert, T., & Tillerson, J.L. (2000). Intervention strategies for degeneration of dopamine neurons in Parkinsonism. Optimizing behavioural assessment of outcome. In: Emerich DF, Sandberg PR (Eds) central nervous system diseases: innovative models of CNS diseases from molecule to therapy. Humana, Totowa 131–151. Schallert, T., & Tillerson, J.L. (2000). Intervention strategies for degeneration of dopamine neurons in Parkinsonism. Optimizing behavioural assessment of outcome. In: Emerich DF, Sandberg PR (Eds) central nervous system diseases: innovative models of CNS diseases from molecule to therapy. Humana, Totowa 131–151.
Zurück zum Zitat Schallert T, Woodlee MT (2005) Motor systems: orienting and placing. In: Whishaw I, Kolb B (eds) The behaviour of the laboratory rat: a handbook with tests. Oxford University Press, New York, pp 129–140 Schallert T, Woodlee MT (2005) Motor systems: orienting and placing. In: Whishaw I, Kolb B (eds) The behaviour of the laboratory rat: a handbook with tests. Oxford University Press, New York, pp 129–140
Zurück zum Zitat Schapira AH, Jenner P (2011) Etiology and pathogenesis of Parkinson's disease. Movement Disorder 26:1049–1055CrossRef Schapira AH, Jenner P (2011) Etiology and pathogenesis of Parkinson's disease. Movement Disorder 26:1049–1055CrossRef
Zurück zum Zitat Simola N, Morelli M, Carta AR (2007) The 6-hydroxydopamine model of Parkinson’s disease. Neurotox Res 11(3–4):151–167CrossRefPubMed Simola N, Morelli M, Carta AR (2007) The 6-hydroxydopamine model of Parkinson’s disease. Neurotox Res 11(3–4):151–167CrossRefPubMed
Zurück zum Zitat Smith AD, Castro SL, Zigmond MJ (2002) Stress-induced Parkinson's disease: a working hypothesis. Physiology and Behaviour 77(4–5):527–531CrossRef Smith AD, Castro SL, Zigmond MJ (2002) Stress-induced Parkinson's disease: a working hypothesis. Physiology and Behaviour 77(4–5):527–531CrossRef
Zurück zum Zitat Sullivan AM, Toulouse A (2011) Neurotrophic factors for the treatment of Parkinson's disease. Cytokine Growth Factor Rev 22(3):157–165CrossRefPubMed Sullivan AM, Toulouse A (2011) Neurotrophic factors for the treatment of Parkinson's disease. Cytokine Growth Factor Rev 22(3):157–165CrossRefPubMed
Zurück zum Zitat Tillerson JL, Cohen AD, Philhower J, Miller GW, Zigmond MJ, Schallert T (2001) Forced limb-use effects on the behavioural and neurochemical effects of 6-hydroxydopamine. J Neurosci 21:4427–4435PubMed Tillerson JL, Cohen AD, Philhower J, Miller GW, Zigmond MJ, Schallert T (2001) Forced limb-use effects on the behavioural and neurochemical effects of 6-hydroxydopamine. J Neurosci 21:4427–4435PubMed
Zurück zum Zitat Toumi ML, Merzoug S, Tahraoui A (2016) Effects of quercetin on predator stress-related hematological and behavioural alterations in pregnant rats and their offspring. J Biosci 41(2):237–249CrossRefPubMed Toumi ML, Merzoug S, Tahraoui A (2016) Effects of quercetin on predator stress-related hematological and behavioural alterations in pregnant rats and their offspring. J Biosci 41(2):237–249CrossRefPubMed
Zurück zum Zitat Weis J, Saxena S, Evangelopoulo ME, Kruttgen A (2003) Trophic factors in neurodegenerative disorders. Life 55:353–357PubMed Weis J, Saxena S, Evangelopoulo ME, Kruttgen A (2003) Trophic factors in neurodegenerative disorders. Life 55:353–357PubMed
Zurück zum Zitat Xue YQ, Zhao LR, Guo WP, Duan WM (2007) Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease. Neuroscience 146(3):1245–1258CrossRefPubMed Xue YQ, Zhao LR, Guo WP, Duan WM (2007) Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease. Neuroscience 146(3):1245–1258CrossRefPubMed
Zurück zum Zitat Zhang W, Hetzel A, Shah B, Atchley D, Blume SR, Padival MA, Rosenkranz JA (2014) Greater physiological and behavioural effects of interrupted stress pattern compared to daily restraint stress in rats. PLoS One 9(7):e102247CrossRefPubMedPubMedCentral Zhang W, Hetzel A, Shah B, Atchley D, Blume SR, Padival MA, Rosenkranz JA (2014) Greater physiological and behavioural effects of interrupted stress pattern compared to daily restraint stress in rats. PLoS One 9(7):e102247CrossRefPubMedPubMedCentral
Metadaten
Titel
Post 6-OHDA lesion exposure to stress affects neurotrophic factor expression and aggravates motor impairment
verfasst von
Phumzile Nomfundo Ngema
Musa Vuyisile Mabandla
Publikationsdatum
20.03.2017
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 4/2017
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-017-9988-1

Weitere Artikel der Ausgabe 4/2017

Metabolic Brain Disease 4/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.